genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • GEN Protocols
  • Resources
    • Summits
    • Webinars
    • GEN Live
    • eBooks/Perspectives
    • Podcasts
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • – INSIDE –
    PRECISION MEDICINE
Search
  • About GEN
  • Contact GEN
  • Subscribe/Update Preferences
  • Log In
Sign in
Welcome! Log into your account
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • Lonza facility
      Bioprocessing

      Lonza Plans New Fill & Finish Facility in Stein, Switzerland

      Bioprocessing

      Harnessing Bacteria to Make Jet Fuel: Not Just An “Explosive Idea?”

      © ia_64 - Fotolia.com
      Drug Discovery

      Potential Therapeutic Treatment for Androgenetic Alopecia

      mosquitoes
      Dengue

      Mosquitoes Find Humans Infected with Zika or Dengue Viruses More Attractive

      Cruise ship in caribbean sea
      Infectious Diseases

      Enteric Viruses Shown Capable of Spreading via Saliva

  • Insights
    • AllTrends for 2020Trends for 2021
      Proteomics
      Insights

      Single-Cell Functional Proteome Profiling Uncovers Novel Targets for Alzheimer’s Disease

      Biotechnology
      Artificial Intelligence

      AI Can Make a Difference on the Factory Floor If Biopharma…

      mRNA Vaccine Vial For HIV/AIDS On Pink Background
      Bioprocessing

      Separation Technique Adjusted for mRNA Vaccine Boom

      Scientist monitoring fermentation operation
      Antibodies

      Combatting Therapeutic-Protein Aggregation

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

      coronavirus
      A-Lists

      Seven Biopharma Trends to Watch in 2022

      A-Lists

      Six of the Best Reports from the Front Line of Biotechnology

      3d illustration of a  part of RNA chain from which the deoxyribonucleic acid or DNA is composed
      A-Lists

      Top 10 RNA-Based Biopharmas

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • GEN Protocols
  • Resources
    • Summits
    • Webinars
    • GEN Live
    • eBooks/Perspectives
    • Podcasts
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • – INSIDE –
    PRECISION MEDICINE
Home Therapeutics Enzyme Replacement Therapy

Enzyme Replacement Therapy

  • Anti-Ulcerants
  • Antibacterials
  • Antibiotics
  • Anticoagulants
  • Antidiabetics
  • Antifungals
  • Antivirals
  • Autoimmune Disease Drugs
  • Biologics
  • Biosimilars
  • Cardiovascular Drugs
  • Cellular Therapeutics
  • Combination Therapies
  • Dermatologic Drugs
  • Enzyme Replacement Therapy
  • Generics
  • Hormone Replacement Therapy
  • Immuno-oncology
  • Immunotherapies
  • Lipid Regulators
  • Mental Health Drugs
  • Oncologics
  • Orphan Drugs
  • Pain
  • Protein Therapeutics
  • Psychoactive Drugs
  • Radiopharmaceuticals
  • Respiratory Drugs
  • Traditional Chinese Medications
  • Vaccines
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Enzyme Replacement Therapy

    Rubius Therapeutics Closes $120M Financing, Plans Trials Next Year

    Enzyme Replacement Therapy

    Alexion to Eliminate 7% of Workforce

    Enzyme Replacement Therapy

    Amicus Cuts Jobs, Overhauls GSK Collab, and Acquires Callidus

    Enzyme Replacement Therapy

    Lonza to Manufacture Heart Failure Enzyme Replacement Therapy

    Enzyme Replacement Therapy

    Genzyme Gets FDA, EMA Approvals for Production Plant in Waterford, Ireland

    Enzyme Replacement Therapy

    Protalix, Pfizer Report FDA Approval of Plant-Derived Gaucher Disease ERT Elelyso

    Enzyme Replacement Therapy

    EMA Green-Lights Shire’s Manufacturing Site in Lexington, MA, for Gaucher Therapy

    Enzyme Replacement Therapy

    Alexion Pays $610M to Buy Enobia for Hypophosphatasia ERT Candidate

    Enzyme Replacement Therapy

    Oxyrane Raises $26.5M to Take Lead Enzyme Replacement Therapy Through Phase...

    Enzyme Replacement Therapy

    Enobia Raises $40M to Further Develop Phase II-Stage ERT for Hypophosphatasia

    The new entity will be publicly traded and will focus on orphan drugs. [© Sergey Ilin - Fotolia.com]
    Enzyme Replacement Therapy

    Synageva Merges with Trimeris in All-Stock Deal

    Enzyme Replacement Therapy

    Halozyme and Intrexon to Develop Subcutaneous Recombinant Alpha 1-Antitrypsin Replacement Therapy

    Funds will be used to continue clinical development of lead LAL deficiency enzyme replacement therapy.[© Bobby4237 - Fotolia.com]
    Enzyme Replacement Therapy

    Synageva Raises $25M Through Private Placement with Existing Investors

    Enzyme Replacement Therapy

    Enobia Chooses Lonza for Commercial-Scale Manufacture of Its Enzyme-Replacement Therapy

    Pharmacological chaperone is designed to stabilize a-GAL A and restore its activity.[Sergey Ilin-Fotolia.com]
    Enzyme Replacement Therapy

    GSK Pays Amicus $30M Up Front for Phase III Fabry Disease...

    12Page 1 of 2

    Recently Featured

    Lonza Plans New Fill & Finish Facility in Stein, Switzerland

    Lonza Plans New Fill & Finish Facility in Stein, Switzerland

    Harnessing Bacteria to Make Jet Fuel: Not Just An “Explosive Idea?”

    Harnessing Bacteria to Make Jet Fuel: Not Just An “Explosive Idea?”

    Potential Therapeutic Treatment for Androgenetic Alopecia

    Potential Therapeutic Treatment for Androgenetic Alopecia

    Mosquitoes Find Humans Infected with Zika or Dengue Viruses More Attractive

    Mosquitoes Find Humans Infected with Zika or Dengue Viruses More Attractive

    Read the Digital Edition

    Explore

    • About GEN
    • Contact GEN
    • GEN Protocols
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Inside Precision Medicine
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up